Journal Article (Letter)

DKFZ-2023-00796

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Selpercatinib Controls Central Nervous System Disease in Patients With NSCLC With RET Fusion.

Zhao, B. (First author)DKFZ* ; Xing, H. ; Ma, W.

2023
Elsevier Amsterdam

Note: #EA:D170#

---

Contributing Institute(s):

1. KKE Neuroimmunologie und Hirntumorimmunologie (D170)
2. DKTK HD zentral (HD01)

Research Program(s):

1. 314 - Immunologie und Krebs (POF4-314) (POF4-314)

Appears in the scientific report 2023

---

Database coverage:
; Allianz-Lizenz ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Essential Science Indicators ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---